BioLineRx In-Licenses Treatment for Acute Kidney Injury

BioLineRx signed a worldwide, exclusive license agreement with Gene Vector Technologies for the development and commercialization of BL-4040, a drug for the treatment of acute kidney injury (AKI).
Genetic Engineering & biotechnology News